Interactive modules by Olga Goodman, MD.Copyright protected · Read termsClose terms

All RheumaView™ interactive modules, quizzes and educational cases are original works developed by Olga Goodman, MD.

Without the author’s prior written permission, you may not copy or republish these modules or their components; extract, reuse or modify their original software code (“engines”); or use that code to build your own modules, quizzes or other products.

You may not claim these works as your own or remove or replace the author’s name or copyright notices. When quoting material, credit Olga Goodman, MD, identify the source and include a direct link to the original.

Free or public access is provided for learning and does not grant permission to copy, adapt or redistribute the materials. Unauthorized use of protected material may constitute copyright infringement. Exceptions and limitations provided by applicable law remain unaffected.

Sharing direct links to the modules is welcome.

© 2026 Olga Goodman, MD. All rights reserved.

Spondyloarthritis family · A closer look at PsA

PsA in adolescence: moving into adult care

A successful transition keeps treatment, monitoring and everyday life connected while a young person gradually takes a larger role in their care.

Olga Goodman, MD · Sources checked 27 September 2026

Chapter 14 of 21

The essentials

Transition is a process, not a single birthday or a referral letter. Know who is responsible until the first adult appointment, how prescriptions will continue and which eye checks are still needed.

A childhood diagnosis needs its own history

Arthritis with psoriasis beginning in childhood may be described as juvenile psoriatic arthritis, within juvenile idiopathic arthritis (JIA). The paediatric team considers the child's pattern of disease and development. An adult PsA treatment pathway cannot simply be copied into paediatric care. 4

Take the original diagnosis, age at onset, joint and skin history, eye history and previous treatment responses to the adult team. If terminology changes, ask what this changes in practice. A new label should not erase useful clinical history.

Make the handover visible

EULAR/PReS recommends starting preparation in early adolescence, with coordination between paediatric and adult teams and clear transfer documentation. Timing should reflect readiness and the local service. 3

Ask for the name of the receiving clinician, the first appointment and a contact if it is delayed. Decide who prescribes medicines and checks results during the gap. Put refill and blood-test dates in the calendar before the final paediatric visit.

Build independence one task at a time

Try leading part of the visit: describe the last week, explain what each medicine is for, or ask one question. Practise ordering a refill and knowing which result needs follow-up. If reminders or help with injections are useful, keep them. Independence can include asking for support.

Agree which tasks belong to the young person, family and team. Ask for time to discuss sensitive concerns privately and clarify how messages and records are shared in the new service. Discuss relationships, contraception, alcohol or other substances, and mood without waiting for a crisis.

Keep eye care and treatment checks on the plan

Some JIA-associated uveitis can be silent. Feeling well or having no red eye does not replace the scheduled ophthalmology examination. Other forms can cause a painful red eye and light sensitivity, which need urgent assessment. Ask which monitoring schedule applies to this young person. 4, 13

A new clinic should receive the medicine schedule, monitoring results and vaccination history. Paediatric doses, licensing and vaccine decisions need age-specific review; do not increase to an adult dose or interrupt treatment just because care is transferring. 4, 9

School, work and changes of home

Discuss the practical effect of morning stiffness, fatigue, hand pain or appointments on study and work. Ask for the adjustments that solve a particular problem: extra time between rooms, a suitable workstation, or flexibility around treatment. The paediatric team can help coordinate school support. 4

Before moving for education or work, check how to obtain prescriptions, store medicine, attend monitoring and contact a local service. Write down what to do if a dose is missed or an illness develops, using the individual treatment instructions.

A compact transfer record

Keep an accessible copy of the agreed record. It can travel with the young person instead of relying on memory or a parent being available.

A compact transfer record
RecordInclude
Disease storyDiagnosis and onset; joints, skin and eyes; allergies; treatments tried, benefit and reasons for stopping.
Current careExact medicine schedule; latest monitoring; next tests and eye appointment; vaccination record.
People and datesReceiving team; first appointment; refill responsibility; urgent contact; agreed family support.

Go deeper

Readiness is more useful than an age threshold

A young person may confidently discuss symptoms but still need help obtaining prescriptions. Another may manage injections but struggle to seek support for low mood. These are different tasks, not a single pass-or-fail test. Use the gaps to decide what to practise next.

The transition recommendations are consensus-based and apply across juvenile rheumatic diseases. They support continuity and participation; they do not supply a drug regimen for juvenile psoriatic arthritis or guarantee the same service in every country. 3

Questions for your visit

  1. Who is responsible for my treatment before I have actually seen the adult team?
  2. Which eye and laboratory checks must continue?
  3. Which care task can I practise myself next, and where do I still want help?
  4. How can I discuss private concerns and arrange support at school, university or work?

When to seek urgent help

A painful red eye, light sensitivity or a sudden change in vision needs urgent assessment. A newly hot, swollen joint, especially with fever or feeling unwell, also needs prompt assessment.

Sources & evidence notes

Sources checked 27 September 2026

The dates identify the versions used. General guidance needs an individual decision; drug labels, age-specific indications and local vaccination schedules also matter.

  1. Foster HE et al. EULAR/PReS standards for transitional care in juvenile-onset rheumatic disease. Ann Rheum Dis. 2017.
  2. NIAMS. Juvenile idiopathic arthritis: diagnosis, treatment and steps to take. Reviewed July 2024.
  3. Bass AR et al. ACR guideline for vaccinations in rheumatic and musculoskeletal diseases. 2022 guideline. Arthritis Rheumatol. 2023.
  4. NIAMS. Juvenile idiopathic arthritis: symptoms, types and causes.

Educational information for patients and caregivers. This personal publication is not the clinic portal and does not provide individual diagnosis or treatment. Discuss medication changes with your own care team.

© 2026 Olga Goodman, MD · A RheumaView publication. Copying without attribution prohibited.

Share this page

FacebookLinkedInXWhatsAppTelegram

Topics: Care coordinationPsoriasisPsoriatic arthritisQuality of lifeSpondyloarthritis